Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) is now available.
Jacobio Pharmaceuticals Group Co., Ltd. announced an increase in shareholdings by parties acting in concert, who purchased 240,000 shares at an average price of HK$7.05. This move reflects strong confidence in the company’s development prospects and growth potential, with the concert parties now holding 25.35% of the total issued shares. The company assures that the transactions were conducted in compliance with applicable laws and regulations, indicating a positive outlook for stakeholders.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$3.70 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and commercialization of innovative drugs, with a market focus on enhancing its growth potential and long-term investment value.
Average Trading Volume: 6,795,128
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.54B
For a thorough assessment of 1167 stock, go to TipRanks’ Stock Analysis page.